Rocket


News + Filings
Transactions



ATWOOD BRIAN G

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
06/13/2023Atreca, Inc.BCELGrantStock Option (right to buy)12k$1.18$14.2k 06/13/2023
06/08/2022Atreca, Inc.BCELGrantStock Option (right to buy)12k$2.09$25.1k 06/08/2022
10/08/2021PHOENIX BIOTECH ACQUISITION CORP. Other (acquisition)Class B Common Stock25k$0.00$0By Phoenix Biotech Sponsor, LLC10/08/2021
06/10/2021Clovis Oncology, Inc.CLVSGrantStock Option (right to buy)42.2k$5.97$252.1k 06/10/2021
06/09/2021Atreca, Inc.BCELGrantStock Option (right to buy)12k$10.27$123.2k 06/09/2021
01/12/2021eFFECTOR Therapeutics, Inc. Other (disposition)Class B Common Stock25k$0.00$0By LWAC D&O LLC01/12/2021
12/09/2020Atreca, Inc.BCELGiftStock Option (right to buy)12k$17.87$214.4kBy Atwood-Edminster Trust dtd 4/2/0012/09/2020
12/09/2020Atreca, Inc.BCELGiftStock Option (right to buy)12.5k$4.56$57k 12/09/2020
12/09/2020Atreca, Inc.BCELGiftStock Option (right to buy)12.5k$4.56$57kBy Atwood-Edminster Trust dtd 4/2/0012/09/2020
12/09/2020Atreca, Inc.BCELGiftStock Option (right to buy)34.2k$12.66$432.5k 12/09/2020
12/09/2020Atreca, Inc.BCELGiftStock Option (right to buy)34.2k$12.66$432.5kBy Atwood-Edminster Trust dtd 4/2/0012/09/2020
12/09/2020Atreca, Inc.BCELGiftStock Option (right to buy)12k$17.87$214.4k 12/09/2020
11/09/2020Clovis Oncology, Inc.CLVSExerciseStock Option (right to buy)6.9k$3.08$21.2k 11/09/2020
06/10/2020Atreca, Inc.BCELGrantStock Option (right to buy)12k$17.87$214.4k 06/10/2020
06/04/2020Clovis Oncology, Inc.CLVSGrantStock Option (right to buy)40.1k$6.48$260.1k 06/04/2020
08/20/2019Clovis Oncology, Inc.CLVSExerciseStock Option (right to buy)25.9k$0.29$7.5k 08/20/2019
06/24/2019Atreca, Inc.BCELConversionClass A Common Stock8.8k$0.00$0By Atwood-Edminster Trust06/24/2019
06/24/2019Atreca, Inc.BCELConversionSeries A Preferred Stock4.5k$0.00$0By Atwood-Edminster Trust06/24/2019
06/24/2019Atreca, Inc.BCELConversionSeries B Preferred Stock4.3k$0.00$0By Atwood-Edminster Trust06/24/2019
06/06/2019Clovis Oncology, Inc.CLVSGrantStock Option (right to buy)28.9k$14.66$423.4k 06/06/2019
10/11/2018Clovis Oncology, Inc.CLVSGrantStock Option (right to buy)14.8k$27.92$412.4k 10/11/2018
06/26/2017Clovis Oncology, Inc.CLVSOther (acquisition)Common Stock212$0.00$0See Footnote06/26/2017
06/26/2017Clovis Oncology, Inc.CLVSOther (acquisition)Common Stock5k$0.00$0See Footnote06/26/2017
06/08/2017Clovis Oncology, Inc.CLVSGrantStock Option (right to buy)10k$59.56$595.6k 06/08/2017
05/25/2017PHASERX, INC.PZRXGrantEmployee Stock Option (right to buy)14k$1.08$15.1k 05/25/2017
06/22/2016OPGEN INCOPGNGrantStock Option Award12.5k$1.35$16.9k 06/22/2016
06/20/2016VERACYTE, INC.VCYTGrantStock Option (Right to Buy)10k$5.28$52.8k 06/20/2016
06/09/2016Clovis Oncology, Inc.CLVSGrantStock Option (right to buy)10k$15.23$152.3k 06/09/2016
06/01/2016PHASERX, INC.PZRXGrantEmployee Stock Option (right to buy)28.2k$5.08$143.3k 06/01/2016
05/23/2016PHASERX, INC.PZRXSaleCommon Stock435$0.01$4.4By Versant Side Fund III, L.P.05/23/2016
05/23/2016PHASERX, INC.PZRXSaleCommon Stock1.1k$0.01$10.8By Versant Side Fund III, L.P.05/23/2016
05/23/2016PHASERX, INC.PZRXPurchaseCommon Stock3.5k$5.00$17.6kBy Versant Side Fund III, L.P.05/23/2016
05/23/2016PHASERX, INC.PZRXSaleCommon Stock73.6k$0.01$736.2By Versant Venture Capital III, L.P.05/23/2016
05/23/2016PHASERX, INC.PZRXSaleCommon Stock182.9k$0.01$1.8kBy Versant Venture Capital III, L.P.05/23/2016
05/23/2016PHASERX, INC.PZRXPurchaseCommon Stock596.5k$5.00$3MBy Versant Venture Capital III, L.P.05/23/2016
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy